AAPL   314.75 (-0.63%)
MSFT   177.01 (-2.51%)
FB   222.07 (-4.36%)
GOOGL   1,400.64 (-1.46%)
AMZN   2,348.37 (-3.03%)
NVDA   325.52 (-6.65%)
BABA   197.55 (-2.07%)
MU   44.48 (-2.88%)
TSLA   792.56 (-3.21%)
AMD   50.09 (-5.83%)
T   31.80 (+3.18%)
GILD   73.69 (+0.70%)
DIS   120.27 (-0.56%)
NFLX   399.60 (-3.26%)
BAC   25.13 (+3.46%)
BA   145.26 (+0.37%)
AAPL   314.75 (-0.63%)
MSFT   177.01 (-2.51%)
FB   222.07 (-4.36%)
GOOGL   1,400.64 (-1.46%)
AMZN   2,348.37 (-3.03%)
NVDA   325.52 (-6.65%)
BABA   197.55 (-2.07%)
MU   44.48 (-2.88%)
TSLA   792.56 (-3.21%)
AMD   50.09 (-5.83%)
T   31.80 (+3.18%)
GILD   73.69 (+0.70%)
DIS   120.27 (-0.56%)
NFLX   399.60 (-3.26%)
BAC   25.13 (+3.46%)
BA   145.26 (+0.37%)
AAPL   314.75 (-0.63%)
MSFT   177.01 (-2.51%)
FB   222.07 (-4.36%)
GOOGL   1,400.64 (-1.46%)
AMZN   2,348.37 (-3.03%)
NVDA   325.52 (-6.65%)
BABA   197.55 (-2.07%)
MU   44.48 (-2.88%)
TSLA   792.56 (-3.21%)
AMD   50.09 (-5.83%)
T   31.80 (+3.18%)
GILD   73.69 (+0.70%)
DIS   120.27 (-0.56%)
NFLX   399.60 (-3.26%)
BAC   25.13 (+3.46%)
BA   145.26 (+0.37%)
AAPL   314.75 (-0.63%)
MSFT   177.01 (-2.51%)
FB   222.07 (-4.36%)
GOOGL   1,400.64 (-1.46%)
AMZN   2,348.37 (-3.03%)
NVDA   325.52 (-6.65%)
BABA   197.55 (-2.07%)
MU   44.48 (-2.88%)
TSLA   792.56 (-3.21%)
AMD   50.09 (-5.83%)
T   31.80 (+3.18%)
GILD   73.69 (+0.70%)
DIS   120.27 (-0.56%)
NFLX   399.60 (-3.26%)
BAC   25.13 (+3.46%)
BA   145.26 (+0.37%)
Log in

NASDAQ:NITENightstar Therapeutics SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$25.41
MA: $25.41
$25.41
52-Week Range N/A
Volume40 shs
Average Volume185,808 shs
Market Capitalization$852.25 million
P/E RatioN/A
Dividend YieldN/A
Beta2.84

SEC Filings

Nightstar Therapeutics (NASDAQ:NITE) SEC Filings

DateFilerForm TypeView
02/04/2020
12:01 PM
Nightstar Therapeutics (Subject)
Woodford Investment Management Ltd (Filed by)
Form SC 13G/A
06/17/2019
3:02 PM
Nightstar Therapeutics (Filer)
Form 15-12B
06/12/2019
2:52 PM
New Enterprise Associates 15, L.P. (Filed by)
Nightstar Therapeutics (Subject)
Form SC 13D/A
06/11/2019
3:30 PM
Nightstar Therapeutics (Issuer)
Syncona Holdings Ltd (Reporting)
Syncona Investment Management Ltd (Reporting)
Syncona Ltd (Reporting)
Syncona Portfolio Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:22 PM
Nightstar Therapeutics (Filer)
Form S-8 POS
06/10/2019
4:21 PM
Nightstar Therapeutics (Filer)
Form S-8 POS
06/10/2019
4:19 PM
Nightstar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:44 PM
MOTT DAVID M (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:43 PM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
MAKOWER JOSHUA (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
Nightstar Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:42 PM
Nightstar Therapeutics (Issuer)
Yoon Seokho Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:41 PM
Nightstar Therapeutics (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:41 PM
Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:39 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:38 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:37 PM
McArthur James G (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:36 PM
Lubner David Charles (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:27 AM
Nightstar Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/29/2019
3:07 PM
Nightstar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:18 PM
Nightstar Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:09 PM
Nightstar Therapeutics (Filer)
Form 10-K/A
04/26/2019
11:21 AM
Nightstar Therapeutics (Filer)
Form DEFA14A
04/25/2019
10:50 AM
Nightstar Therapeutics (Subject)
Polygon Global Partners LLP (Filed by)
Form SC 13D
04/16/2019
8:01 AM
Nightstar Therapeutics (Filer)
Form DEFA14A
04/10/2019
9:19 AM
Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
04/09/2019
8:51 AM
Nightstar Therapeutics (Filer)
Form DEFA14A
04/09/2019
8:13 AM
Nightstar Therapeutics (Filer)
Form DEFM14A
04/03/2019
8:02 PM
Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
8:01 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
8:01 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
8:00 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
8:01 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 4/A
03/21/2019
8:00 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 3/A
03/18/2019
4:31 PM
Nightstar Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
8:30 AM
Nightstar Therapeutics (Filer)
Form PREM14A
03/14/2019
4:00 PM
BIOGEN INC. (Filed by)
Nightstar Therapeutics (Subject)
Form SC 13D
03/13/2019
6:22 AM
New Enterprise Associates 15, L.P. (Filed by)
Nightstar Therapeutics (Subject)
Form SC 13D/A
03/05/2019
7:49 AM
Nightstar Therapeutics (Filer)
Form DEFA14A
03/04/2019
8:22 AM
Nightstar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
8:20 AM
Nightstar Therapeutics (Filer)
Form DEFA14A
02/14/2019
2:45 PM
Nightstar Therapeutics (Subject)
Woodford Investment Management Ltd (Filed by)
Form SC 13G
02/14/2019
2:04 PM
Nightstar Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/13/2019
4:06 PM
Nightstar Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
Form SC 13G/A
02/13/2019
3:54 PM
Nightstar Therapeutics (Issuer)
Syncona Holdings Ltd (Reporting)
Syncona Investment Management Ltd (Reporting)
Syncona Ltd (Reporting)
Syncona Portfolio Ltd (Reporting)
Form 3/A
02/12/2019
8:31 AM
Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2019
8:07 PM
MOTT DAVID M (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
8:06 PM
Nightstar Therapeutics (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
8:05 PM
McArthur James G (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
8:03 PM
Lubner David Charles (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
8:02 PM
Hollowood Christopher J (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
8:00 PM
Cobb Paula K (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
8:06 PM
Nightstar Therapeutics (Issuer)
Yoon Seokho Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
8:05 PM
Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
8:04 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
8:03 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
8:01 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
8:13 PM
Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
8:12 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
8:12 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
8:10 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
8:09 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4/A
01/09/2019
8:08 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4/A
01/09/2019
8:05 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 3/A
01/09/2019
8:03 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 3/A
01/07/2019
8:20 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:29 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
8:32 PM
MOTT DAVID M (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:21 PM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
MAKOWER JOSHUA (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
Nightstar Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Sonsini Peter W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:10 PM
Cobb Paula K (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:09 PM
Nightstar Therapeutics (Issuer)
Whitcup Scott M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:08 PM
McArthur James G (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:07 PM
Lubner David Charles (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:05 PM
Hollowood Christopher J (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:05 PM
Nightstar Therapeutics (Issuer)
Yoon Seokho Bryan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:04 PM
Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:03 PM
Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:02 PM
Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:01 PM
FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
8:01 PM
Nightstar Therapeutics (Issuer)
Syncona Holdings Ltd (Reporting)
Syncona Ltd (Reporting)
Syncona Portfolio Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2018
4:04 PM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
7:27 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
7:07 AM
Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/09/2018
8:39 AM
New Enterprise Associates 15, L.P. (Filed by)
Nightstar Therapeutics (Subject)
Form SC 13D/A
09/28/2018
3:03 PM
Nightstar Therapeutics (Filer)
Form 424B4
09/27/2018
11:15 PM
Nightstar Therapeutics (Filer)
Form EFFECT
09/26/2018
8:58 PM
Nightstar Therapeutics (Filer)
Form F-1/A
09/25/2018
3:20 PM
Nightstar Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
09/25/2018
3:09 PM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2018
7:06 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2018
5:15 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2018
4:30 PM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2018
7:31 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/10/2018
8:41 AM
Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
08/07/2018
4:26 PM
Nightstar Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
07/27/2018
3:11 PM
Nightstar Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
06/14/2018
6:35 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2018
4:15 PM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2018
7:31 AM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2018
1:54 PM
Nightstar Therapeutics (Filer)
Form CT ORDER
05/01/2018
4:16 PM
Nightstar Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2018
4:29 PM
Nightstar Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.